R4 Ballot #1 #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.3.0: (v3.5.0: R4 Ballot 2). #2). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4

Plandefinition-opioidcds-07

Clinical Decision Support Work Group Maturity Level : N/A Ballot Status : Informative Compartments : Not linked to any defined compartments

This is the narrative for the resource. See also the XML or , JSON or Turtle format. This example conforms to the profile PlanDefinition .

Generated Narrative with Details

id : opioidcds-07

url : http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-07

identifier : cdc-opioid-guidance (OFFICIAL)

version : 0.1.0

name : cdc-opioid-07

title : CDC Opioid Prescribing Guideline Recommendation #7

type : ECA Rule (Details : {http://hl7.org/fhir/plan-definition-type {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status : draft

date : 19/03/2018

publisher : Centers for Disease Control and Prevention (CDC)

description : Clinicians should evaluate benefits and harms with patients within 1 to 4 weeks of starting opioid therapy for chronic pain or of dose escalation. Clinicians should evaluate benefits and harms of continued therapy with patients every 3 months or more frequently.

useContext : ,

jurisdiction : United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose : CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage : If benefits do not outweigh harms of continued opioid therapy, clinicians should optimize other therapies and work with patients to taper opioids to lower dosages or to taper and discontinue opioids.

copyright : © CDC 2016+.

topic : Opioid Prescribing (Details )

contributor author : , , ,

relatedArtifact : ,

library : Library/opioidcds-recommendation-07

action

title : Existing patient should be evaluated for risk of continued opioid therapy.

description : Checking if the trigger prescription meets the inclusion criteria for recommendation #7 workflow.

documentation :

trigger :

Conditions

- Kind Description Language Expression
* applicability Check whether the existing patient, without an end of life condition or risk assessment in the past 90 days, has taken an opioid-with-abuse-potential for 7 of the past 10 days or 63 of the past 90 days. text/cql Inclusion Criteria

groupingBehavior : visual-group

selectionBehavior : exactly-one

dynamicValue

path : action.title

expression : Get Summary

dynamicValue

path : action.description

expression : Get Detail

dynamicValue

path : action.extension

expression : Get Indicator

Actions

-
*
*
*

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.